SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-22-009784
Filing Date
2022-03-16
Accepted
2022-03-16 16:30:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13 D/A brhc10035309_sc13da.htm SC 13D/A 48938
  Complete submission text file 0001140361-22-009784.txt   50502
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Subject) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42217 | Film No.: 22745282
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BOW STREET CAMBRIDGE MA 02138
Business Address
Cherington Charles (Filed by) CIK: 0001448698 (see all company filings)

Type: SC 13D/A